Debrecen, Hungary

Arpad Buzna

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arpad Buzna. Retrieved from https://idiyas.com/inventor/arpad-buzna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arpad Buzna: Innovator in Antibiotic Compositions

Introduction

Arpad Buzna is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of antibiotic research, particularly with his innovative patent that enhances the effectiveness of antibiotic treatments.

Latest Patents

Arpad Buzna holds a patent for "Synergistic antibiotic compositions." This invention describes how the antibiotic primycin can synergize the effects of other antibiotics when used in specific proportions. The patent specifies that primycin should constitute between 5 to 50% by weight of the total antibiotic content to achieve optimal results.

Career Highlights

Buzna is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a company known for its pharmaceutical products. His work at this organization has allowed him to focus on developing innovative solutions in antibiotic therapies.

Collaborations

Throughout his career, Arpad Buzna has collaborated with notable colleagues, including Gabor Kulcsar and Jeno Soltesz. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Arpad Buzna's contributions to antibiotic research through his patent on synergistic antibiotic compositions highlight his role as an innovator in the field. His work continues to influence the development of more effective antibiotic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…